
Instil Bio: PD-L1/VEGF Bispecific Targeting With Unique Enhancements (TIL)
Tingting Ji/iStock via Getty Images Instil Bio, Inc. (NASDAQ:TIL) recently traded higher on the back of analyst raising their price target on shares because of how much the PD-1/VEGF bispecific antibody space is heating up. […]